|
|
| Patria (Recombinant NDV Vectored Vaccine for SARS-CoV-2) / National Autonomous University of Mexico, Avimex, Mexican Social Security Institute (0 Trials) |
|
| patritumab (U3-1287) / Amgen, Daiichi Sankyo (1 Trials) |
|
| patritumab deruxtecan (U3-1402) / Daiichi Sankyo, Merck (MSD) (8 Trials) |
|
| patupilone (EPO 906) / Novartis (3 Trials) |
|
| Pavacol-D (pholcodine) / Alliance (0 Trials) |
|
| pavinetant (AZD4901) / AstraZeneca, Tempest Therap (0 Trials) |
|
| pavurutamab (AMG 701) / Amgen (0 Trials) |
|
| PAX-1-004 / Komipharm (0 Trials) |
|
| paxalisib (GDC-0084) / Kazia, SoVarGen (8 Trials) |
|
| Paxlovid (nirmatrelvir/ritonavir) / Pfizer (0 Trials) |
|
| PB (MDT)-3030 (insulin glargine biosimilar) / Paras Biopharma (0 Trials) |
|
| PB-718 / PegBio (0 Trials) |
|
| PB-CD19 CAR-T / Kyoto Prefectural University of Medicine (0 Trials) |
|
| PB007 (ustekinumab biosimilar) / Genefar (0 Trials) |
|
| PB016 (vedolizumab biosimilar) / Genefar (0 Trials) |
|
| PB101 / Panolos Biosci (0 Trials) |
|
| PB103 / Chongqing Precision Biotech (0 Trials) |
|
| PB1120 / PhaseBio Pharma (0 Trials) |
|
| PB357 / Puma, Pfizer (0 Trials) |
|
| PB6440 / Ji Xing Pharma (0 Trials) |
|
| PBAL05 / Passage Bio (0 Trials) |
|
| PBB-8-SQ / Ascension Healthcare (0 Trials) |
|
| PBCAR 20A / Precision BioSci (0 Trials) |
|
| PBCAR19B / Precision BioSci (0 Trials) |
|
| PBCAR269A / Precision BioSci (0 Trials) |
|
| PBCAR269B / Precision BioSci (0 Trials) |
|
| PBCM06 / Passage Bio (0 Trials) |
|
| PBD-C06 / Simcere (0 Trials) |
|
| PBF-1129 / Palobiofarma (0 Trials) |
|
| PBF-1650 / Palobiofarma (0 Trials) |
|
| PBF-2828 / Palobiofarma (0 Trials) |
|
| PBF-677 / Palobiofarma (0 Trials) |
|
| PBF-680 / Palobiofarma (2 Trials) |
|
| PBF-999 / Palobiofarma (0 Trials) |
|
| PBFT02 / Passage Bio (0 Trials) |
|
| PBGENE-HBV / Precision BioSci (0 Trials) |
|
| PBGENE-PCSK9 / Precision BioSci (0 Trials) |
|
| PBGENE-PH1 / Precision BioSci (0 Trials) |
|
| PBGM01 / Passage Bio (0 Trials) |
|
| PBI 1308 / Liminal BioSci, Darier (0 Trials) |
|
| PBI 4419 / Liminal BioSci (0 Trials) |
|
| PBI-1402 / Liminal BioSci (0 Trials) |
|
| PBI-200 / Pyramid Biosci (0 Trials) |
|
| PBI-410 / Pyramid Biosci (0 Trials) |
|
| PBI-4425 / Liminal BioSci (0 Trials) |
|
| PBI-4547 / Liminal BioSci (0 Trials) |
|
| pbi-shRNA K-ras LP / Gradalis (0 Trials) |
|
| pbi-shRNA PDX-1 LP / Gradalis (0 Trials) |
|
| pbi-shRNA STMN1 LP / Gradalis (0 Trials) |
|
| PBI100 / Pyramid Biosci (0 Trials) |
|
| PBKR03 / Passage Bio (0 Trials) |
|
| PBL 1427 / Panacea Biotec (0 Trials) |
|
| PBML04 / Passage Bio (0 Trials) |
|
| PBP1502 (adalimumab biosimilar) / Prestige BioPharma, Huons (0 Trials) |
|
| PBP1505 (infliximab biosimilar) / Prestige BioPharma (0 Trials) |
|
| PBP1506 (rituximab biosimilar) / Prestige BioPharma (0 Trials) |
|
| PBP1507 (etanercept biosimilar) / Prestige BioPharma (0 Trials) |
|
| PBP1602 (aflibercept biosimilar) / Prestige BioPharma (0 Trials) |
|
| PBP1710 / Prestige BioPharma (0 Trials) |
|
| PBP2001 (ramucirumab biosimilar) / Prestige BioPharma (0 Trials) |
|
| PBT2 / Alterity Therap, The Florey Institute of Neuroscience and Mental Health (0 Trials) |
|
| PBT519 / Alterity Therap (0 Trials) |
|
| PBX-001 / PinotBio (0 Trials) |
|
| PBX-002 / PinotBio (0 Trials) |
|
| PBX-003 / PinotBio, ProEn Therap (0 Trials) |
|
| PBX-004 / PinotBio (0 Trials) |
|
| PC-1005 gel / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| PC786 / Pulmocide (0 Trials) |
|
| PCA062 / MorphoSys, Novartis (0 Trials) |
|
| PCAR-019 / PersonGen Biomedicine (2 Trials) |
|
| PCAR-119 / PersonGen Biomedicine (1 Trials) |
|
| pCAR-19B / Chongqing Precision Biotech (0 Trials) |
|
| PCART3 / MediSix Therap (0 Trials) |
|
| PCART30 / MediSix Therap (0 Trials) |
|
| PCART7 / MediSix Therap (0 Trials) |
|
| PCC-1 / Glenmark (0 Trials) |
|
| PCI 27483 / AbbVie (0 Trials) |
|
| PCI-45261 / AbbVie (0 Trials) |
|
| PCO371 / Roche (0 Trials) |
|
| PCS12852 / Processa Pharma (0 Trials) |
|
| PCS202101 / AnnJi Pharma (0 Trials) |
|
| PCS202102 / AnnJi Pharma (0 Trials) |
|
| PCSK 9 vaccine / Pfizer (0 Trials) |
|
| PCT-3010 / PolyCore Therap (0 Trials) |
|
| PCT-3012 / PolyCore Therap (0 Trials) |
|
| PCUR-101 / Pellficure (1 Trials) |
|
| PCV14 / Biological E Ltd (0 Trials) |
|
| PCV24 / Merck (MSD) (0 Trials) |
|
| PCV7 / Pfizer (0 Trials) |
|
| PCX12 / Therapyx, University of Rochester (0 Trials) |
|
| PD 360324 / Pfizer (1 Trials) |
|
| PD-1 knockout engineered T cells / Anhui Kedgene Biotech (1 Trials) |
|
| PD-1 knockout engineered T cells / Chengdu MedGenCell (1 Trials) |
|
| PD-1 Knockout T Cells / Cell Biotech (0 Trials) |
|
| PD-1 mAb / Cellular Biomedicine (0 Trials) |
|
| PD-407824 / Weill Cornell Medical College (0 Trials) |
|
| PD-BT2238 / BioArctic (0 Trials) |
|
| PD-L1 inhibitor millamolecule / BMS (0 Trials) |
|
| PD-L1 ISAC / Bolt Biotherap (0 Trials) |
|
| PD-L1 programmed CD34+ immunotherapy / Fate Therap (0 Trials) |
|
| PD-L1.t-haNK / ImmunityBio (0 Trials) |
|
| PD-L1.TNK / Sorrento, ImmunityBio (0 Trials) |
|
| PD01/PD04+AD05 / AFFiRiS (0 Trials) |
|
| PD03A / AFFiRiS (0 Trials) |
|
| PD04 / AFFiRiS (0 Trials) |
|
| PD1 TurboCAR T cells / Allogene Therap (0 Trials) |
|
| PD1-Dependent IL-2 / Roche (0 Trials) |
|
| PD1-LAG3 Bispecific antibody / Sutro Biopharma (0 Trials) |
|
| PD1601 / BioArctic (0 Trials) |
|
| PD1602 / BioArctic (0 Trials) |
|
| PD173074 / Pfizer (0 Trials) |
|
| PD198306 / Pfizer, Geisel School of Medicine at Dartmouth, University of Montreal (0 Trials) |
|
| PD2015 / P2D Biosci (0 Trials) |
|
| PD2024 / P2D Biosci (0 Trials) |
|
| PD2244 / P2D Biosci (0 Trials) |
|
| PD98059 / Wayne State University (0 Trials) |
|
| PDC*lung / PDC line Pharma (0 Trials) |
|
| PDC*mel / PDC line Pharma (0 Trials) |
|
| PDC-APB / Hapten Sci (0 Trials) |
|
| PDCNeo / PDC line Pharma (0 Trials) |
|
| PDE10 inhibitor / BioCrea (0 Trials) |
|
| PDE2 inhibitor / Intra-Cellular Therapies (0 Trials) |
|
| PDE4B inhibitor / Shionogi (0 Trials) |
|
| PDE4B inhibitor / Cerevel Therap (0 Trials) |
|
| PDE6A gene therapy / STZ eyetrial (0 Trials) |
|
| PDE7 beta MAGE A4 autologous SPEAR T cells / Adaptimmune (0 Trials) |
|
| PDE9 inhibitor / Intra-Cellular Therapies (0 Trials) |
|
| PDgrastim (filgrastim biosimilar) / Pooyesh Darou (0 Trials) |
|
| PDL1-Dependent IFN-α / Bonum Therap (0 Trials) |
|
| PDNO / Attgeno (0 Trials) |
|
| PDpoetin (epoetin alfa biosimilar) / Pooyesh Darou (0 Trials) |
|
| PDS0101 / PDS Biotech (0 Trials) |
|
| PDS0102 / National Cancer Institute, PDS Biotech (0 Trials) |
|
| PDS0103 / PDS Biotech, National Cancer Institute - Bethesda (0 Trials) |
|
| PDS0104 / PDS Biotech (0 Trials) |
|
| PDS01ADC / PDS Biotech (9 Trials) |
|
| PDS0203 / PDS Biotech, Farmacore, Blanver (0 Trials) |
|
| PDS0204 / PDS Biotech, Farmacore (0 Trials) |
|
| PE0105 / Shanghai Yunyi Health Technology (0 Trials) |
|
| PE0116 / HyaMab (0 Trials) |
|
| peanut native extract / Leti Pharma (0 Trials) |
|
| peboctocogene camaparvovec (DTX201) / Ultragenyx (1 Trials) |
|
| PEC Delivery and Gene Editing / Precigen (0 Trials) |
|
| PEC-Direct (PEC-01) / Vertex (1 Trials) |
|
| PEC-Encap (encapsulated human islet cell therapy) / Vertex (1 Trials) |
|
| PEC-QT / CRISPR Therap, Vertex (0 Trials) |
|
| pecavaptan (BAY1753011) / Bayer (0 Trials) |
|
| Pediarix (diphtheria, tetanus toxoids and acellular pertussis adsorbed, hepatitis b and inactivated poliovirus vaccine) / GSK (0 Trials) |
|
| Pediatex (carbinoxamine) / Royalty (0 Trials) |
|
| pediatric brain cancer neurofibromatosis-1 vaccine / Calviri (0 Trials) |
|
| Pedmark (sodium thiosulfate) / Fennec Pharma (0 Trials) |
|
| pefcalcitol (M 518101) / Maruho (0 Trials) |
|
| PEG filgrastim (pegfilgrastim biosimilar) / Harvest Moon (0 Trials) |
|
| PEG Interferon / Beijing Kawin (0 Trials) |
|
| PEG Neutrogen (pegfilgrastim biosimilar) / Virchow Group (0 Trials) |
|
| peg recombinant human coagulation factor VIII-Fc fusion protein (FRSW117) / (0 Trials) |
|
| PEG-Endostar (pegylated recombinant human endostatin) / Simcere (0 Trials) |
|
| PEG-Filastin (pegfilgrastim biosimilar) / Incepta Pharma (0 Trials) |
|
| PEG-GCSF (pegfilgrastim biosimilar) / NAL Pharma (0 Trials) |
|
| PEG-GCSF (pegfilgrastim biosimilar) / PharmaEssentia (0 Trials) |
|
| Peg-GCSF (pegfilgrastim biosimilar) / CPL Biologicals (0 Trials) |
|
| Peg-grafeel (pegfilgrastim biosimilar) / EMD Serono, Dr. Reddy’s (0 Trials) |
|
| peg-Interferon Alfa-2b / AMEGA Biotech (0 Trials) |
|
| PEG-interferon beta (TRK-560) / Toray (0 Trials) |
|
| Peg-Neutropine (pegfilgrastim biosimilar) / AMEGA Biotech (0 Trials) |
|
| PEG-relaxin (BMS-986046) / BMS (0 Trials) |
|
| Peg-ReliGrast (pegfilgrastim biosimilar) / Reliance Life Sci (0 Trials) |
|
| PEG-somatropin (ARX201) / EMD Serono, J&J (0 Trials) |
|
| PEG-talazoparib (PLX376) / ProLynx (0 Trials) |
|
| PEG-VEGF antag / Bolder BioTech (0 Trials) |
|
| pegacaristim (PEG-rHuMGDF) / Amgen, Fujifilm Kyowa Kirin Biologics, BMS (0 Trials) |
|
| PegaGen (pegfilgrastim biosimilar) / CinnaGen (0 Trials) |
|
| pegapamodutide (OPK88003) / OPKO Health, LeaderMed (0 Trials) |
|
| Pegasys (pegylated interferon α -2a) / Roche (48 Trials) |
|
| pegbelfermin (BMS-986036) / BMS (0 Trials) |
|
| Pegberon (ypeginterferon alpha-2b) / Xiamen Amoytop Biotech (1 Trials) |
|
| pegcantratinib (SNA-120) / Sienna (0 Trials) |
|
| Pegcyte (pegfilgrastim biosimilar) / Nanogen Biopharma (0 Trials) |
|
| pegenzileukin (SAR444245) / Sanofi, Innovent Biologics (0 Trials) |
|
| pegerythropoietin injection (RD01) / 3SBio (0 Trials) |
|
| Pegex (pegfilgrastim biosimilar) / Emcure (0 Trials) |
|
| pegfilgrastim biosimilar / Biogenomics (0 Trials) |
|
| pegfilgrastim biosimilar / Pharmstandard OJSC (0 Trials) |
|
| pegfilgrastim biosimilar / Hangzhou Jiuyuan Gene Engineering (0 Trials) |
|
| pegfilgrastim biosimilar / Eurofarma (0 Trials) |
|
| pegfilgrastim biosimilar / Helvetic (0 Trials) |
|
| pegfilgrastim biosimilar / Biocure Technology (0 Trials) |
|
| pegfilgrastim biosimilar / Epygen (0 Trials) |
|
| pegfilgrastim biosimilar / Lunan Pharma (0 Trials) |
|
| pegfilgrastim biosimilar / AqVida (0 Trials) |
|
| pegfilgrastim biosimilar / Geneleuk Biopharma (0 Trials) |
|
| PeggTrust (pegfilgrastim biosimilar) / Panacea Biotec (0 Trials) |
|
| Pegihep (peginterferon-α-2b biosimilar) / Zydus Lifesci (0 Trials) |
|
| pegilodecakin (LY3500518) / Eli Lilly (2 Trials) |
|
| peginterferon alfa 2b 48kDA (BIP48) / Oswaldo Cruz Foundation (0 Trials) |
|
| peginterferon beta-1a (ARX424) / EMD Serono (0 Trials) |
|
| peginterferon lambda-1a (BMS-914143) / Eiger, Stanford University (5 Trials) |
|
| Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD) (0 Trials) |
|
| Peglamda (peginterferon lamda 1) / Nanogen Biopharma (0 Trials) |
|
| Pegnano (pegylated interferon-α-2a biosimilar) / Nanogen Biopharma (0 Trials) |
|
|